Intrinsic Value of S&P & Nasdaq Contact Us

EUDA Health Holdings Limited EUDA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • SG • USD

SharesGrow Score
37/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

EUDA Health Holdings Limited (EUDA) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.

Analysts estimate Earnings Per Share (EPS) of $-0.58 and revenue of $0.01B for the next fiscal year.

Earnings Per Share (EPS) track record: 2024: actual $-0.47 vs est $-0.58 (beat +19%). Analyst accuracy: 77%.

EUDA Analyst Ratings

Buy
1
Ratings
1 Buy
Based on 1 analysts giving stock ratings to EUDA Health Holdings Limited in the past 3 months
Rating breakdown
Buy
1 100%
100%
Buy
1 analysts
0%
Hold
0 analysts
0%
Sell
0 analysts

EPS Estimates — EUDA

77%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2024 Actual –$0.47 vs Est –$0.58 ▲ 23.4% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.

Revenue Estimates — EUDA

73%
Analyst Accuracy
Fair
1 year compared
Actual vs Estimate
2024 Actual $0.004B vs Est $0.005B ▼ 26.5% off
Revenue Trend
Analysts forecast significant revenue growth ahead.
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message